View in EDS

A novel antibody against CD300c ameliorates cognitive deficits and reduces pathology in the late-stage of APP/PS1 mouse model.

Saved in:
Bibliographic Details
Title: A novel antibody against CD300c ameliorates cognitive deficits and reduces pathology in the late-stage of APP/PS1 mouse model.
Authors: Lee S; CentricsBio, Inc., Seoul, Republic of Korea.; Department of Life Sciences, Ewha Womans University, Seoul, Republic of Korea., Choi BJ; Department of Physiology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Park MH; Department of Physiology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Park S; CentricsBio, Inc., Seoul, Republic of Korea., Kim J; CentricsBio, Inc., Seoul, Republic of Korea., Jin HK; Department of Laboratory Animal Medicine, College of Veterinary Medicine, Kyungpook National University, Daegu, Republic of Korea., Shim H; Department of Life Sciences, Ewha Womans University, Seoul, Republic of Korea., Jeon JW; CentricsBio, Inc., Seoul, Republic of Korea., Bae JS; Department of Physiology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Source: Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2026 Jun 23, pp. 13872877261458360. Date of Electronic Publication: 2026 Jun 23.
Publication Type: Journal Article
Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 9814863 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-8908 (Electronic) Linking ISSN: 13872877 NLM ISO Abbreviation: J Alzheimers Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1875-8908
DOI:10.1177/13872877261458360